Apr 20, 2022 / 09:00PM GMT
Operator
Greetings. Welcome to the Navidea business update, company strategy and clinical update. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, Dr. Michael Rosol. You may begin.
Michael Stanley Rosol - Navidea Biopharmaceuticals, Inc. - Senior VP & Chief Medical Officer
Thank you, and thank you all for joining us today for this update and Q&A session. This call is being webcast live on our website, ir.navidea.com, and a replay will be made available. Following prepared remarks, we will be conducting an open question-and-answer segment focused on our strategy and clinical updates that will be moderated by me, Mike Rosol; and include the Chair of our Board of Directors, Alex Cappello, joined by our Vice Chair of the Board, Kim Scott, who's here with me in Dublin, Ohio; and Erika Eves, our VP of Finance and Administration, who's also here with me in Dublin, Ohio.
During the course of this conference call, we will be making forward-looking statements regarding future events and the
Navidea Biopharmaceuticals Inc To Discuss Company Strategy and Clinical Update Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot